ID
37149
Descripción
Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02404558
Link
https://clinicaltrials.gov/show/NCT02404558
Palabras clave
Versiones (1)
- 4/7/19 4/7/19 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
4 de julio de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Rheumatoid Arthritis NCT02404558
Eligibility Rheumatoid Arthritis NCT02404558
- StudyEvent: Eligibility
Descripción
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Descripción
Age
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0001779
Descripción
Interleukin-6 Antagonist | Interleukin-6 Receptor Antagonist
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3864917
- UMLS CUI [2]
- C3819026
Descripción
Glucocorticoid Parenteral Injection | Glucocorticoid Intra-Articular Injection
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0017710
- UMLS CUI [1,2]
- C1555373
- UMLS CUI [2,1]
- C0017710
- UMLS CUI [2,2]
- C0021488
Descripción
Prednisone U/day | Equivalent U/day | Prednisone Dosage Change
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0032952
- UMLS CUI [1,2]
- C0456683
- UMLS CUI [2,1]
- C0205163
- UMLS CUI [2,2]
- C0456683
- UMLS CUI [3,1]
- C0032952
- UMLS CUI [3,2]
- C0178602
- UMLS CUI [3,3]
- C0392747
Descripción
DMARDs | Immunosuppressive Agents | TNF-inhibitors | Biological agents Targeting Rheumatoid Arthritis
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0242708
- UMLS CUI [2]
- C0021081
- UMLS CUI [3]
- C3653350
- UMLS CUI [4,1]
- C0005515
- UMLS CUI [4,2]
- C1521840
- UMLS CUI [4,3]
- C0003873
Descripción
Study Subject Participation Status | Investigational New Drugs | Therapies, Investigational
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2]
- C0013230
- UMLS CUI [3]
- C0949266
Descripción
Tuberculosis | Tuberculosis Suspected | High risk of Tuberculosis
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0041296
- UMLS CUI [2,1]
- C0041296
- UMLS CUI [2,2]
- C0750491
- UMLS CUI [3,1]
- C0332167
- UMLS CUI [3,2]
- C0041296
Descripción
Fever Treatment required for | Chronic infectious disease Treatment required for | Persistent infection Treatment required for | Recurrent infections Treatment required for
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0015967
- UMLS CUI [1,2]
- C0332121
- UMLS CUI [2,1]
- C0151317
- UMLS CUI [2,2]
- C0332121
- UMLS CUI [3,1]
- C1264606
- UMLS CUI [3,2]
- C0332121
- UMLS CUI [4,1]
- C0239998
- UMLS CUI [4,2]
- C0332121
Descripción
Study Subject Participation Status Consideration Additional
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C0518609
- UMLS CUI [1,3]
- C1524062
Similar models
Eligibility Rheumatoid Arthritis NCT02404558
- StudyEvent: Eligibility
C0008902 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C3819026 (UMLS CUI [2])
C1555373 (UMLS CUI [1,2])
C0017710 (UMLS CUI [2,1])
C0021488 (UMLS CUI [2,2])
C0456683 (UMLS CUI [1,2])
C0205163 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0032952 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0392747 (UMLS CUI [3,3])
C0021081 (UMLS CUI [2])
C3653350 (UMLS CUI [3])
C0005515 (UMLS CUI [4,1])
C1521840 (UMLS CUI [4,2])
C0003873 (UMLS CUI [4,3])
C0013230 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
C0041296 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0332167 (UMLS CUI [3,1])
C0041296 (UMLS CUI [3,2])
C0332121 (UMLS CUI [1,2])
C0151317 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
C1264606 (UMLS CUI [3,1])
C0332121 (UMLS CUI [3,2])
C0239998 (UMLS CUI [4,1])
C0332121 (UMLS CUI [4,2])
C0518609 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])